Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies Publisher Pubmed



Dezfouli M1, 2 ; Bergstrom S2 ; Skattum L3, 4 ; Abolhassani H1, 5 ; Neiman M2 ; Torabirahvar M6 ; Franco Jarava C7 ; Martinnalda A8 ; Ferrer Balaguer JM9 ; Slade CA10, 11 ; Roos A12 ; Fernandez Pereira LM13 ; Lopeztrascasa M14 ; Gonzalezgranado LI15 Show All Authors
Authors
  1. Dezfouli M1, 2
  2. Bergstrom S2
  3. Skattum L3, 4
  4. Abolhassani H1, 5
  5. Neiman M2
  6. Torabirahvar M6
  7. Franco Jarava C7
  8. Martinnalda A8
  9. Ferrer Balaguer JM9
  10. Slade CA10, 11
  11. Roos A12
  12. Fernandez Pereira LM13
  13. Lopeztrascasa M14
  14. Gonzalezgranado LI15
  15. Allendemartinez LM16
  16. Mizuno Y17
  17. Yoshida Y18
  18. Friman V19
  19. Lundgren A20
  20. Aghamohammadi A5
  21. Rezaei N5
  22. Hernandezgonzalez M7
  23. Von Dobeln U21
  24. Truedsson L3
  25. Hara T17
  26. Nonoyama S18
  27. Schwenk JM2
  28. Nilsson P2
  29. Hammarstrom L1
Show Affiliations
Authors Affiliations
  1. 1. Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden
  2. 2. Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology SciLifeLab, Stockholm, Sweden
  3. 3. Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden
  4. 4. Clinical Immunology and Transfusion Medicine, Region Skane, Lund, Sweden
  5. 5. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Immunology Department, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
  8. 8. Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
  9. 9. Immunology, Hospital Universitari Son Espases/Institut d'Investigacio Sanitaria Illes Balears, Palma, Spain
  10. 10. Royal Melbourne Hospital, Melbourne, VIC, Australia
  11. 11. The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
  12. 12. Department of Microbiology and Immunology, Sint Antonius Hospital, Nieuwegein, Netherlands
  13. 13. Department of Immunology, Hospital San Pedro de Alcantara, Caceres, Spain
  14. 14. Departamento de Medicina, Hospital La Paz Institute for Health Research (IdiPAZ), Universidad Autonoma de Madrid and Complement Research Group, Madrid, Spain
  15. 15. Primary Immunodeficiencies Unit, Department of Pediatrics, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (I+12), Madrid, Spain
  16. 16. Immunology Department, University Hospital 12 de Octubre, Research Institute Hospital 12 Octubre (I+12), Madrid, Spain
  17. 17. Fukuoka Children's Hospital, Kyushu University, Fukuoka, Japan
  18. 18. Department of Pediatrics, National Defense Medical College, Saitama, Japan
  19. 19. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
  20. 20. Departments of Infectious Diseases, Central Hospital, Kristianstad, Sweden
  21. 21. Division of Metabolic Diseases, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden

Source: Frontiers in Immunology Published:2020


Abstract

The clinical outcomes of primary immunodeficiencies (PIDs) are greatly improved by accurate diagnosis early in life. However, it is not common to consider PIDs before the manifestation of severe clinical symptoms. Including PIDs in the nation-wide newborn screening programs will potentially improve survival and provide better disease management and preventive care in PID patients. This calls for the detection of disease biomarkers in blood and the use of dried blood spot samples, which is a part of routine newborn screening programs worldwide. Here, we developed a newborn screening method based on multiplex protein profiling for parallel diagnosis of 22 innate immunodeficiencies affecting the complement system and respiratory burst function in phagocytosis. The proposed method uses a small fraction of eluted blood from dried blood spots and is applicable for population-scale performance. The diagnosis method is validated through a retrospective screening of immunodeficient patient samples. This diagnostic approach can pave the way for an earlier, more comprehensive and accurate diagnosis of complement and phagocytic disorders, which ultimately lead to a healthy and active life for the PID patients. © Copyright © 2020 Dezfouli, Bergstrom, Skattum, Abolhassani, Neiman, Torabi-Rahvar, Franco Jarava, Martin-Nalda, Ferrer Balaguer, Slade, Roos, Fernandez Pereira, Lopez-Trascasa, Gonzalez-Granado, Allende-Martinez, Mizuno, Yoshida, Friman, Lundgren, Aghamohammadi, Rezaei, Hernandez-Gonzalez, von Dobeln, Truedsson, Hara, Nonoyama, Schwenk, Nilsson and Hammarstrom.